Literature DB >> 20027579

Measuring the heart in pulmonary arterial hypertension (PAH): implications for trial study size.

William M Bradlow1, Marina L Hughes, Niall G Keenan, Chiara Bucciarelli-Ducci, Ravi Assomull, J Simon R Gibbs, Raad H Mohiaddin.   

Abstract

PURPOSE: To calculate the sample size for a theoretical pulmonary arterial hypertension (PAH) randomized controlled trial (RCT) by using cardiovascular magnetic resonance (CMR) imaging to determine the repeatability of measures between two scans.
MATERIALS AND METHODS: Two same-day examinations from 10 PAH patients were analyzed manually and semiautomatically. Study size was calculated from the standard deviation (SD) of repeatability. Different approaches to right-ventricle (RV) mass were investigated, agreement between methods tested and interobserver reproducibility measured by Bland-Altman analysis to explore how the PAH heart might be best measured.
RESULTS: Repeatability was good for almost all manually-measured indices but poor for semiautomated measurement of RV mass and left-ventricle (LV) end-diastolic volume (EDV). Thus, for an RCT (power, 80%; significance level, 5%) analyzing "outcome" indices (RVEDV, LVEDV, RV ejection fraction, and RV mass; anticipated change: 10 mL, 10 mL, 3%, and 10 g, respectively) manually, 34 patients are required compared to 78 if analysis is semiautomated. RV mass was repeatable if the interventricular septum was divided between ventricles or if wholly apportioned to the LV. Limits of agreement between manual and semiautomated analyses were unsatisfactory for RV measures and interobserver reproducibility was worse for semiautomated than manual analysis.
CONCLUSION: Manual is more robust than semiautomated analysis and at present should be favored in RCTs in PAH as it leads to lower sample size requirements. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20027579     DOI: 10.1002/jmri.22011

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  18 in total

Review 1.  Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension.

Authors:  Benjamin H Freed; Amit R Patel; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

2.  The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload.

Authors:  Mariëlle C van de Veerdonk; Sophie A Dusoswa; J Tim Marcus; Harm-Jan Bogaard; Onno Spruijt; Taco Kind; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-04       Impact factor: 2.357

3.  Reproducibility of peak filling and peak emptying rate determined by cardiovascular magnetic resonance imaging for assessment of biventricular systolic and diastolic dysfunction in patients with pulmonary arterial hypertension.

Authors:  Christoffer Göransson; Niels Vejlstrup; Jørn Carlsen
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-22       Impact factor: 2.357

4.  Imaging right ventricular function to predict outcome in pulmonary arterial hypertension.

Authors:  Melanie J Brewis; Alessandro Bellofiore; Rebecca R Vanderpool; Naomi C Chesler; Martin K Johnson; Robert Naeije; Andrew J Peacock
Journal:  Int J Cardiol       Date:  2016-05-13       Impact factor: 4.164

5.  Cardiovascular magnetic resonance in pulmonary hypertension.

Authors:  William M Bradlow; J Simon R Gibbs; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2012-01-18       Impact factor: 5.364

6.  Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Authors:  Paul M Hassoun; Roham T Zamanian; Rachel Damico; Noah Lechtzin; Rubina Khair; Todd M Kolb; Ryan J Tedford; Olivia L Hulme; Traci Housten; Chiara Pisanello; Takahiro Sato; Erica H Pullins; Celia P Corona-Villalobos; Stefan L Zimmerman; Mohamed A Gashouta; Omar A Minai; Fernando Torres; Reda E Girgis; Kelly Chin; Stephen C Mathai
Journal:  Am J Respir Crit Care Med       Date:  2015-11-01       Impact factor: 21.405

7.  Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function.

Authors:  Corey E Ventetuolo; Nandita Mitra; Fei Wan; Ani Manichaikul; R Graham Barr; Craig Johnson; David A Bluemke; Joao A C Lima; Hari Tandri; Pamela Ouyang; Steven M Kawut
Journal:  Eur Respir J       Date:  2015-12-02       Impact factor: 16.671

8.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

9.  Multimodal assessment of right ventricle overload-metabolic and clinical consequences in pulmonary arterial hypertension.

Authors:  Remigiusz Kazimierczyk; Lukasz A Malek; Piotr Szumowski; Stephan G Nekolla; Piotr Blaszczak; Dorota Jurgilewicz; Marcin Hladunski; Bozena Sobkowicz; Janusz Mysliwiec; Ryszard Grzywna; Wlodzimierz J Musial; Karol A Kaminski
Journal:  J Cardiovasc Magn Reson       Date:  2021-05-10       Impact factor: 5.364

Review 10.  Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art.

Authors:  Andrew J Swift; Jim M Wild; Scott K Nagle; Alejandro Roldán-Alzate; Christopher J François; Sean Fain; Kevin Johnson; Dave Capener; Edwin J R van Beek; David G Kiely; Kang Wang; Mark L Schiebler
Journal:  J Thorac Imaging       Date:  2014-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.